126 related articles for article (PubMed ID: 37216287)
1. In vitro-based prediction of human plasma concentrations of food-related compounds.
Kitaguchi T; Ito M; Ohno K; Ota N; Kobayashi K; Sato H; Iwao T; Matsunaga T; Tanaka M; Hisaka A
ALTEX; 2023; 40(4):595-605. PubMed ID: 37216287
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Evaluation of Membrane Permeability and UDP-Glucuronosyltransferase-Mediated Metabolism of Food-Derived Compounds Using Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells.
Kitaguchi T; Mizota T; Ito M; Ohno K; Kobayashi K; Ogawa I; Qiu S; Iwao T; Hanioka N; Tanaka M; Matsunaga T
Drug Metab Dispos; 2022 Jan; 50(1):17-23. PubMed ID: 34670778
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Function and Features of Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells for Analyzing Peptide Drug Intestinal Absorption Profiles.
Itagaki M; Kamei N; Takeda-Morishita M
J Pharm Sci; 2023 Sep; 112(9):2591-2595. PubMed ID: 37230251
[TBL] [Abstract][Full Text] [Related]
4. Updated in Silico Prediction Methods for Fractions Absorbed and Key Input Parameters of 355 Disparate Chemicals for Physiologically Based Pharmacokinetic Models for Time-Dependent Plasma Concentrations after Virtual Oral Doses in Humans.
Adachi K; Shimizu M; Yamazaki H
Biol Pharm Bull; 2022 Dec; 45(12):1812-1817. PubMed ID: 36171106
[TBL] [Abstract][Full Text] [Related]
5. In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models.
Sjögren E; Thörn H; Tannergren C
Mol Pharm; 2016 Jun; 13(6):1763-78. PubMed ID: 26926043
[TBL] [Abstract][Full Text] [Related]
6. Predictive Performance of Next Generation Physiologically Based Kinetic (PBK) Model Predictions in Rats Based on In Vitro and In Silico Input Data.
Punt A; Louisse J; Pinckaers N; Fabian E; van Ravenzwaay B
Toxicol Sci; 2022 Feb; 186(1):18-28. PubMed ID: 34927682
[TBL] [Abstract][Full Text] [Related]
7. Predictive performance of next generation human physiologically based kinetic (PBK) models based on in vitro and in silico input data.
Punt A; Louisse J; Beekmann K; Pinckaers N; Fabian E; Van Ravenzwaay B; Carmichael PL; Sorrell I; Moxon TE
ALTEX; 2022; 39(2):221–234. PubMed ID: 35064272
[TBL] [Abstract][Full Text] [Related]
8. Liver and Plasma Concentrations of Food Chemicals after Virtual Oral Doses Extrapolated Using in Silico Estimated Input Pharmacokinetic Parameters to Confirm Reported Liver Toxicity in Rats.
Adachi K; Nakano H; Sato T; Shimizu M; Yamazaki H
Biol Pharm Bull; 2023 Aug; 46(8):1133-1140. PubMed ID: 37316265
[TBL] [Abstract][Full Text] [Related]
9. Successful Prediction of Human Pharmacokinetics After Oral Administration by Optimized Physiologically Based Pharmacokinetics Approach and Permeation Assay Using Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells.
Mayumi K; Akazawa T; Kanazu T; Ohnishi S; Hasegawa H
J Pharm Sci; 2020 Apr; 109(4):1605-1614. PubMed ID: 31884012
[TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of the GastroPlus
Zhang F; Bartels M; Clark A; Erskine T; Auernhammer T; Bhhatarai B; Wilson D; Marty S
SAR QSAR Environ Res; 2018 Nov; 29(11):875-893. PubMed ID: 30286617
[TBL] [Abstract][Full Text] [Related]
11. Impact of in vitro experimental variation in kinetic parameters on physiologically based kinetic (PBK) model simulations.
Punt A; Bos P; Hakkert B; Louisse J
ALTEX; 2023; 40(2):237–247. PubMed ID: 35901496
[TBL] [Abstract][Full Text] [Related]
12. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.
Peters SA
Clin Pharmacokinet; 2008; 47(4):261-75. PubMed ID: 18336055
[TBL] [Abstract][Full Text] [Related]
14. Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine.
Akazawa T; Yoshida S; Ohnishi S; Kanazu T; Kawai M; Takahashi K
Drug Metab Dispos; 2018 Nov; 46(11):1497-1506. PubMed ID: 30135242
[TBL] [Abstract][Full Text] [Related]
15. Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling.
Louisse J; Bosgra S; Blaauboer BJ; Rietjens IM; Verwei M
Arch Toxicol; 2015 Jul; 89(7):1135-48. PubMed ID: 24935252
[TBL] [Abstract][Full Text] [Related]
16. IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies.
Ahmad A; Pepin X; Aarons L; Wang Y; Darwich AS; Wood JM; Tannergren C; Karlsson E; Patterson C; Thörn H; Ruston L; Mattinson A; Carlert S; Berg S; Murphy D; Engman H; Laru J; Barker R; Flanagan T; Abrahamsson B; Budhdeo S; Franek F; Moir A; Hanisch G; Pathak SM; Turner D; Jamei M; Brown J; Good D; Vaidhyanathan S; Jackson C; Nicolas O; Beilles S; Nguefack JF; Louit G; Henrion L; Ollier C; Boulu L; Xu C; Heimbach T; Ren X; Lin W; Nguyen-Trung AT; Zhang J; He H; Wu F; Bolger MB; Mullin JM; van Osdol B; Szeto K; Korjamo T; Pappinen S; Tuunainen J; Zhu W; Xia B; Daublain P; Wong S; Varma MVS; Modi S; Schäfer KJ; Schmid K; Lloyd R; Patel A; Tistaert C; Bevernage J; Nguyen MA; Lindley D; Carr R; Rostami-Hodjegan A
Eur J Pharm Biopharm; 2020 Nov; 156():50-63. PubMed ID: 32805361
[TBL] [Abstract][Full Text] [Related]
17.
Kamiya Y; Handa K; Miura T; Yanagi M; Shigeta K; Hina S; Shimizu M; Kitajima M; Shono F; Funatsu K; Yamazaki H
Chem Res Toxicol; 2021 Feb; 34(2):507-513. PubMed ID: 33433197
[TBL] [Abstract][Full Text] [Related]
18. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry.
Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW
Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631
[TBL] [Abstract][Full Text] [Related]
19. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
[TBL] [Abstract][Full Text] [Related]
20. Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model.
Paixão P; Gouveia LF; Morais JA
Int J Pharm; 2012 Jun; 429(1-2):84-98. PubMed ID: 22449410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
